The CHI3L1 protein-positive rate in patients with lymph node metastasis (85.2%, 23/27) was significantly higher than that in patients without lymph node metastasis (64.5%, 49/76). This evidence concerns the gene CHI3L1 and metastatic malignant neoplasm in the lymph nodes.